4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-21-044391
Options or other derivatives
- Chief Commercial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tardio Jason Chief Commercial Officer | 2021-07-01 | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
Loading xslF345X03/doc4.xml…